[Bushen Anshen针治疗缺陷的绝经前期失眠症:一个随机对照试验]
Wen-Jia Yang1, Na Zhao1, Xin-Tong Yu1
1Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of TCM, Shanghai 200437, China.
Zhongguo zhen jiu = Chinese acupuncture & moxibustion
|June 14, 2023
概括
布申安申针显著改善了患有缺乏症的绝经前失眠患者的睡眠质量. 这种传统中医的方法增强了主观和客观的睡眠测量,提供了一个有前途的治疗选择.
科学领域:
- 传统中国医药 传统中国医药
- 综合医学是一个整体的医学.
- 睡眠医学 睡眠医学
- 针研究 针研究
背景情况:
- 绝经前失眠 (PMI) 是一种常见的疾病,在中国传统医学 (TCM) 中经常与缺陷有关.
- 现有的PMI治疗方法可能存在局限性,需要探索替代疗法.
- 针是TCM的关键组成部分,在治疗各种睡眠障碍方面已经显示出潜力.
研究的目的:
- 评估Bushen Anshen针治疗临断期失眠 (PMI) 的临床有效性,其特点是缺陷.
- 为了比较布申安申针与假针对睡眠质量参数的影响.
主要方法:
- 一项随机对照试验,涉及72名患有PMI或缺乏症的患者.
- 观察组在特定的针点 (Baihui GV 20,Shenshu BL 23,Taixi KI 3,Anmian Extra) 接受了布申安申针,而对照组接受了假针.
- 睡眠质量使用匹兹堡睡眠质量指数 (PSQI) 和多睡眠图 (PSG) 在10次治疗课程之前和之后进行评估.
主要成果:
- 与基线相比,布申安申针组在所有PSQI得分 (睡眠质量,延迟,持续时间,效率,催眠使用,白天功能障碍,总得分) 中显著改善 (P<0.01).
- 透露,布申安申针延长了睡眠时间,提高了睡眠效率,缩短了入睡后的睡眠延迟和清醒时间,并降低了唤醒清醒指数 (P<0.01).
- 与假针组相比,布申安申针导致PSQI得分明显降低,睡眠参数更好,包括睡眠阶段减少N1%和增加N3% (P<0.01).
结论:
- 布申安申针是一种有效的治疗方法,可以改善患者的主观和客观睡眠质量,这些患者经历了与脏缺乏相关的绝经前失眠.
- 这些发现支持使用Bushen Anshen针作为这种患者群体的可行的治疗选择.
- 进一步的研究可以探索这种针方案的长期疗效和潜在机制.
更多相关视频
04:53Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
839
04:59Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
Published on: May 30, 2025
398
相关概念视频
02:07Blind Procedures
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
01:11Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.